European Society of Cardiology/European Atherosclerosis Society Task Force consensus statement on proprotein convertase subtilisin/kexin type 9 inhibitors: practical guidance for use in patients at very high cardiovascular risk. (27th October 2016) - Landmesser, Ulf; John Chapman, M.; Farnier, Michel; Gencer, Baris; Gielen, Stephan; Hovingh, G. Kees; Lüscher, Thomas F.; Sinning, David; Tokgözoğlu, Lale; Wiklund, Olov; Zamorano, Jose Luis; Pinto, Fausto J.; et al.